T43.292A Poisoning by other antidepressants, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by other antidepressants, intentional self-harm, initial encounter
• Technical term: T43.292A

Summary

This code represents intentional self-harm poisoning by antidepressant medications not classified under more specific subcategories, during the initial encounter. It applies when exposure is deliberate, typically due to suicidal intent, and the patient is receiving care for the first time related to this event. The condition is identified based on clinical presentation, medication history, and the nature of the exposure.

Causes

Intentional self-harm poisoning may result from deliberate overdose of antidepressants, often driven by suicidal ideation or intent. This excludes accidental exposure, adverse effects, or underdosing scenarios.

Risk Factors

• History of mental health disorders, such as depression or anxiety, increasing self-harm risk.
• Prior suicide attempts or suicidal ideation.
• Access to antidepressant medications.
• Social isolation or lack of support systems.
• Acute stressors or crises.

Symptoms

• Drowsiness, confusion, or altered mental status.
• Nausea, vomiting, or abdominal pain.
• Rapid heart rate, irregular heartbeat, or blood pressure changes.
• Seizures, tremors, or muscle spasms.
• Respiratory depression or failure.
• Coma or loss of consciousness.

Diagnosis

Diagnosis is based on clinical evaluation, including assessment of mental status, physical examination, and medication history. Toxicology screening may confirm antidepressant exposure. Documentation of intent (self-harm) and encounter type (initial) is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying intent. Interventions may include airway support, activated charcoal, intravenous fluids, and monitoring for complications. Psychiatric evaluation and crisis intervention are essential.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying mental health status. Follow-up includes ongoing psychiatric care, medication management, and safety planning to reduce future risk.

Complications

• Respiratory failure or arrest.
• Cardiac arrhythmias or cardiac arrest.
• Seizures or status epilepticus.
• Rhabdomyolysis or kidney injury.
• Long-term psychiatric or cognitive effects.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Regular mental health check-ins and support.
• Education on medication safety and dosing.
• Crisis hotlines or emergency contacts for at-risk individuals.

When to Seek Professional Help

Seek immediate medical attention if self-harm or overdose is suspected. Contact emergency services or a healthcare provider for urgent evaluation, especially with symptoms like altered consciousness, seizures, or difficulty breathing.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (initial) clearly. Ensure the antidepressant is classified under "other" (not a more specific subcategory) and that the event is acute (initial encounter). Verify no conflicting documentation exists for accidental or therapeutic exposures.